Skip to main content

2022 Provider Letters

Letter Number Subject Date Added to Website
2022-23 Prior Authorization of Herceptin HYLECTA™ – Effective December 21, 2022 11/21/22
2022-22  PA Changes 10/24/22
2022-22  Provider Rate Increase  10/17/22
2022-21  Prior Authorization of Neulasta® – Effective October 15, 2022 9/15/22
2022-20 Re: Mavyret® (Glecaprevir/Pibrentasvir) Update   9/14/22
2022-19 Provider Recoupment - August 17, 2022 9/6/22
2022-18  Re: Assessment/Evaluation and Testing Updated Guidance  9/9/22
2022-17 Re: Removal of Referral for Specific Preventive Codes 8/30/22
2022-16 Re: 340B Drug Discount Program Rule Changes 8/29/22
2022-15 RE: Policy Revisions and Program Updates – Effective Sept. 12, 2022 8/17/22
2022-14 RE: Policy Revisions and Program Updates – Effective Sept. 12, 2022 8/17/22
2022-13 RE: Policy Revisions and Program Updates – Effective Sept. 12, 2022 8/17/22
2022-12 Re: Prior Authorization of Oncaspar® and Mvasi® – Effective September 15, 2022 8/15/22
2022-11 Re: PCMH Behavioral Health Screening Requirement 7/13/22
2022-10 Re: Dental Benefits in Long Term Care Facilities 7/6/22
2022-09 RE: Out-of-State Prepayment Claims Review and Prior Authorization 7/1/22
2022-08 RE: Contract Language 6/24/22
2022-07 RE: Soon-To-Be-Sooners (STBS) Program Information 6/15/22
2022-06 Re: PCMH Mock Audits for Compliance Reviews 6/7/22
2022-05 National Correct Coding Initiative Program Outpatient Facility Claims 4/26/22
2022-04 RE: Yearly Compliance with the Deficit Reduction Act of 2005 - FFY 2021
3/15/22
2022-03 SoonerCare Choice Program Changes
3/1/22
2022-02 Soon-to-be-Sooners Dental Benefits 2/24/22
2022-01 Vaccination Requirement 1/25/22
Last Modified on Jan 26, 2024
Back to Top